Alterity Therapeutics Ltd. (ATHE) Narxning foydaga nisbati
Alterity Therapeutics (ATHE) shifokorlar bemor holati ustidan nazoratni saqlab qolishini ta'minlagan holda, algoritmlar yordamida Parkinson kasalligi dori vositalari sintezini avtomatlashtiradi. Biznes hozirda hamkorlarni jalb qilishdan oldin noyob patologiyalar terapiyasi uchun molekula sinovlarini yakunlashga e'tibor qaratgan. GURU.Markets platformasidagi ushbu narxlar grafigi, unda ko'rsatkich -2.40 darajasida turibdi, kompaniyaning bioetikaga bo'lgan barqaror yondashuvi va kimyoviy chiqindilarni minimallashtirishga tegishli ma'lumotlarni to'ldiradi.
Alterity Therapeutics Limited (ATHE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Alterity Therapeutics|ATHE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Alterity Therapeutics Limited|ATHE - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Alterity Therapeutics Limited|ATHE - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli qarz Alterity Therapeutics|Oraliq qoplash koeffitsiyenti alteritytherapeutics.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ATHE - Sof daromad|Kelajakdagi sof foyda Alterity Therapeutics|ATHE - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Alterity Therapeutics|ATHE - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Alterity Therapeutics Ltd|ATHE - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Alterity Therapeutics|ATHE - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi alteritytherapeutics.com|ATHE - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Alterity Therapeutics
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning umumiy tahlili:Alterity Therapeutics Ltd, ATHE
Alterity Therapeutics (ATHE) barqaror operatsion daromadsiz, investitsiyalar asosida faoliyat yuritgan holda, neyrodegenerativ patologiyalar uchun dori vositalarini ishlab chiqishga e'tibor qaratadi. Bunday sharoitlarda, kompaniyaning tarixiy P/E koeffitsiyenti bozor qiymati va sof foyda o'rtasidagi bog'liqlikni aks ettirib, qaytarilish dinamikasi tahlili orqali past baholangan aktivni "qiymat tuzog'i"dan ajratishga va zarar keltiruvchi biznesga kapitalni muzlatib qo'yishdan qochishga yordam beradi.
Raqobatdosh kompaniyalar
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|CLNN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati PepGen Corp (PEPG)|Narxning foydaga nisbati Jupiter Neurosciences, Inc.|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti Grace Tx GRCE|Narxning foydaga nisbati Firefly Neuroscience, Inc AIFF|KLTO: Narx-foyda multiplikatori|NRSN - Narxning foydaga nisbati|RVPH: Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori
